Sort
15,273 grants matching “antimicrobial resistance”
Geographic origins and dispersal of drug-resistant M. tuberculosis in South Africa: Advancing strategies for early detection
$193,752Tyler Steven Brown · Boston Medical Center · K08 · FY2024 · AI
In vivo Reporters of Mycobacterium tuberculosis ESX-5 Secretion
$193,750Anna Degraff Tischler · University Of Minnesota · R21 · FY2022 · AI
Small molecule inhibitors of bacterial condensins
$193,750Valentin V Rybenkov · University Of Oklahoma · R21 · FY2020 · AI
Investigation of the Flavin Dependent Thymidylate Synthase enzyme as a potential antimicrobial target
$193,750Eric Michael Koehn · San Francisco State University · R16 · FY2025 · GM
Role of SagS signaling and regulatory events in biofilm formation and tolerance
$193,750Karin Sauer · State University Of Ny,Binghamton · R21 · FY2016 · AI
Development of a biological containment strategy for recombinant Lactobacillus reuteri
$193,750Jan-Peter Van Pijkeren · University Of Wisconsin-Madison · R21 · FY2020 · AI
Isoprenoid synthesis and allocation in Staphylococcus aureus
$193,750Neal D. Hammer · Michigan State University · R21 · FY2020 · AI
MHC-II deficient Langerhans cells with compensatory Tc17 plasticity in oral candidiasis
$193,750Massimo Costalonga · University Of Minnesota · R21 · FY2021 · DE
Investigation of the Flavin Dependent Thymidylate Synthase enzyme as a potential antimicrobial target
$193,750Eric Michael Koehn · San Francisco State University · R16 · FY2024 · GM
Determining the mechanisms by which YesMN drives pneumococcal host-to-host transmission
$193,750Muhammad Ammar Zafar · Wake Forest University Health Sciences · R21 · FY2021 · AI
Tracking plasmid spread and transmission in the hospital: A novel tool for infection prevention and control
$193,742Lee H. Harrison · University Of Pittsburgh At Pittsburgh · R21 · FY2024 · AI
Rechargeable Antimicrobial Textiles to Reduce Occupational Risk of Healthcare Personnel
$193,740Yuyu Sun · University Of Massachusetts Lowell · R21 · FY2020 · OH
HIGH-DOSE VITAMIN D AND ANTIMICROBIAL PEPTIDE EXPRESSION IN LUNG FAILURE
$193,650Gregory S Martin · Emory University · R21 · FY2012 · HL
Development of Staphylococcalcidal Human Peptides
$193,650Emory University · R01 · FY2004 · AI
Development of Staphylococcalcidal Human Peptides
$193,650Emory University · R01 · FY2005 · AI
Anti-staphylococcal activities of A. actinomycetemcomitans dispersin B
$193,600Jeffrey B Kaplan · Univ Of Med/Dent Of Nj-Nj Dental School · R21 · FY2010 · AI
Evaluation of a polypeptide vaccine against Acinetobacter infection
$193,591Bernard Pragash Arulanandam · Tufts University Boston · R21 · FY2025 · AI
Molecular basis of Wnt activation by Ehrlichia Wnt ligand mimics
$193,422Jere W McBride · University Of Texas Med Br Galveston · R21 · FY2021 · AI
Identifying the drivers of ESX1 evolution in Mycobacterium tuberculosis
$193,375Sarah M Fortune · Harvard University D/B/A Harvard School Of Public Health · R21 · FY2025 · AI
STAPHYLOCOCCAL VANCOMYCIN AND METHICILLIN RESISTANCE
$193,308Illinois State University · R21 · FY2001 · AI
Characterization of LiaR from multidrug-resistant E. faecium
$193,230Cesar Augusto Arias · University Of Texas Hlth Sci Ctr Houston · R21 · FY2016 · AI
HBD-3: A novel factor orchestrating microbial persistence in suspicious oral lesions
$193,135Aaron Weinberg · Case Western Reserve University · R21 · FY2020 · DE
Diversity of Antimicrobial Use and Emergence of Resistance in Pseudomonas
$193,134Darren R Linkin · University Of Pennsylvania · R21 · FY2008 · AI
Exploring how engineered vancomycin dimers target vancomycin-resistant enterococci (VRE)
$193,131Patrick J Loll · Drexel University · R21 · FY2019 · AI
Chlamydia pneumoniae persistance in the blood vessel
$193,125Lee Ann Campbell · University Of Washington · R21 · FY2016 · AI